Inventor · disambiguated record
Sven Luettke
Also filed as: LUETTKE SVEN
9 granted patents·1 pending application·252 citations·filing 1999–2004
89Inventor score
Top patents by PatentIndex Score
10 records- 0196US6506900B1Process for preparing a scopine ester intermediateBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Jan 14, 2003·102 cites·14 claims
- 0294US6486321B2Process for preparing an anticholinergicBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Nov 26, 2002·92 cites·15 claims
- 0381US6103719ANeurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compoundsBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted Aug 15, 2000·15 cites·27 claims
- 0478US6268389B1Treatment of urinary incontinence by administration of α1L-adrenoceptor agonistsBOEHRINGER INGELHEIM KG·Filed 1999·Granted Jul 31, 2001·34 cites·14 claims
- 0575US7019021B2Compounds and methods for treating urinary incontinenceBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Mar 28, 2006·6 cites·25 claims
- 0667US6858594B2Compounds and methods for treating urinary incontinenceBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Feb 22, 2005·2 cites·6 claims
- 0764US6455700B1Process for preparing guanidine and amidine derivativesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Sep 24, 2002·1 cites·3 claims
- 0852US6429328B2Processes and intermediate compounds for preparing guanidine and amidine derivativesBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Aug 6, 2002·0 cites·2 claims
- 0952US6277840B1Neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Aug 21, 2001·0 cites·7 claims
- 1048US2002147359A1Intermediate compound for preparing guanidine and amidine derivativesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sven Luettke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →